News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Yan Leyfman: Breakthrough in Solid Tumor CAR T Therapy
Yan Leyfman
Jun 12, 2025, 14:10

Yan Leyfman: Breakthrough in Solid Tumor CAR T Therapy

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:

“Breakthrough in Solid Tumor CAR T Therapy!
The first-ever RCT of CAR T-cell therapy in solid tumors shows promise!
Satri-cel (CT041), a CLDN18.2-specific CAR T-cell therapy, significantly improved PFS in patients with advanced gastric or gastro-oesophageal junction cancer vs standard treatments.
– Median PFS: 3.25 mo vs 1.77 mo
– HR: 0.37, p < 0.0001
– Manageable safety profile despite high-grade AEs
These pivotal Phase 2 data support satri-cel as a new third-line option in a population with limited alternatives.”

Title: Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician’s choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial

Journal: The Lancet

Authors: Changsong Qi, Chang Liu, Zhi Peng, Yanqiao Zhang, Jia Wei, Wensheng Qiu

Read the full article.

Solid Tumor

More posts featuring Yan Leyfman on OncoDaily.

cancer CAR T-cell therapy CAR-T therapy Chang Liu Changsong Qi Claudin-18 gastric cancer gastro-oesophageal junction cancer Jia Wei MedNews Week OncoDaily Oncology RCT solid tumor The Lancet Wensheng Qiu Yan Leyfman Yanqiao Zhang Zhi Peng
Special Coverage
Insight
Jul 3, 2025, 17:51
Maximilian Merz: How to Train Your Virtual Twin with 10 Million Euros
Blog
Jul 3, 2025, 17:40
Susanna Fletcher Greer: Striving to Support the Whole Person Behind the Science at the V Foundation
Opinion
Jul 3, 2025, 17:35
Andrew M Wardley: The Essential Role of a Cancer Plan in Shaping the Future of Cancer Care in the UK
Career
Jul 3, 2025, 17:22
George Yaghmour: Honored to Be Named The Leukemia and Lymphoma Society’s 2025 All-Star Top Fundraiser with 255,826 Dollars
Blog
Jul 3, 2025, 17:10
Oliver Bogler: Why I am Learning a New Way to Support Scientists
Blog
Jul 3, 2025, 17:01
Annalisa Saetta: Palliative Care Clerkship Increased Students’ Knowledge and Appreciation for a Holistic Approach
Blog
Jul 3, 2025, 16:46
Priscilla Chan: Accelerating Imaging Science so Researchers Can See Biology More Clearly
Insight
Jul 3, 2025, 16:42
Highlights From ESMO Gastrointestinal Cancers Congress 2025 by Arndt Vogel
Career
Jul 3, 2025, 16:19
David Weinstock Has Been Appointed Head of the Oncology Disease Translational Area in pRED at Roche
Career
Jul 3, 2025, 16:10
Bruno Vialli Has Been Appointed LATAM Procurement Manager for Media, Comms and Events at Sanofi
Insight
Jul 3, 2025, 16:01
Paolo Tarantino: First Positive Phase 3 Trial for a Bispecific ADC
Insight
Jul 3, 2025, 15:48
ASMIRT shares updates on advocacy, research, and student support in Australia - ESTRO